Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A method for predicting ciprofloxacin residues in pigs by a physiological pharmacokinetic model

A technology of physiological pharmacokinetics and model prediction, applied in the field of food safety risk assessment, can solve the problems of low cost, false positive and high cost, and achieve the effect of reducing economic loss and cost

Active Publication Date: 2021-04-16
ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Aiming at the shortcomings of false positives and high cost in the prior art, the present invention provides a method for predicting ciprofloxacin residue in pigs with a physiological pharmacokinetic model, which is simple, feasible and low in cost

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A method for predicting ciprofloxacin residues in pigs by a physiological pharmacokinetic model
  • A method for predicting ciprofloxacin residues in pigs by a physiological pharmacokinetic model
  • A method for predicting ciprofloxacin residues in pigs by a physiological pharmacokinetic model

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0034] A method for predicting ciprofloxacin residues in pigs by a physiological pharmacokinetic model, comprising the following steps:

[0035] Ciprofloxacin is a small molecule substance. For drug residues, we focus on the drug concentration in edible tissues and vital organs, so the model established does not include organs with special physiological barriers. Ciprofloxacin has high fat solubility and strong permeability, and its distribution and transport in the body mainly depends on the blood perfusion rate. Therefore, it can be assumed that the absorption of ciprofloxacin obeys the first-order rate after intramuscular injection, and the distribution in various tissues and organs The speed and degree mainly depend on the blood flow flowing through the tissues and organs, which obeys the speed-limiting distribution of blood flow, is excreted by the kidneys, and obeys the first-order rate. The chamber of the physiological pharmacokinetic model described in the present inve...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the field of food safety risk assessment, and discloses a method for predicting ciprofloxacin residues in pigs with a physiological pharmacokinetic model, comprising the following steps: (1) collecting physiological and anatomical parameters of pigs; (2) obtaining ciprofloxacin Compound-specific parameters of star in pigs; (3) Establishment of a six-compartment model using acslXtreme software; (4) Evaluation of the model. The invention establishes a six-compartment physiological pharmacokinetic model, successfully fits the residual elimination curve of ciprofloxacin in pig muscle, fat, liver and kidney, and the prediction result is consistent with the measured data. The physiological pharmacokinetic model constructed by the present invention can predict the dynamic changes of ciprofloxacin in pig edible tissues under different exposure conditions, and is especially suitable for the residual monitoring of ciprofloxacin in the case of off-label use, and has the advantages of reducing monitoring costs and Easy to operate and other advantages.

Description

technical field [0001] The invention relates to the field of food safety risk assessment, in particular to a method for predicting ciprofloxacin residues in pigs with a physiological pharmacokinetic model. Background technique [0002] Ciprofloxacin has excellent antibacterial effect and pharmacokinetic properties, and is widely used in the pig industry to prevent and control Gram-negative bacteria and mycoplasma infection. Unreasonable use of ciprofloxacin can lead to its residue in the edible tissues of pigs, endangering the health of consumers and the sustainable development of the pig industry. Although the Ministry of Agriculture of my country stipulates the maximum dosage, maximum residue limit and withdrawal period of ciprofloxacin, this cannot effectively eliminate the residue of ciprofloxacin in various off-label applications. The traditional "sampling-slaughter-testing-judgment" residue monitoring method has a certain risk of false positives, and the monitoring co...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): G16B5/00G16B15/30
CPCG16Z99/00
Inventor 张巧艳杨波杨华林晶商小金毛江昌朱凤香
Owner ZHEJIANG ACADEMY OF AGRICULTURE SCIENCES
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com